bioAffinity Technologies Appoints J. Michael Edwards as Chief Financial Officer (CFO)
Position
Chief Financial Officer
Company
bioAffinity Technologies
San AntonioBiotechnologyHealth CareTherapeuticsHealth DiagnosticsDescription
bioAffinity Technologies, Inc. announced the appointment of J. Michael Edwards as Chief Financial Officer (CFO), who will report directly to President and CEO Maria Zannes
Quick answer
bioAffinity Technologies Appoints J. Michael Edwards as Chief Financial Officer (CFO) (October 10, 2024). bioAffinity Technologies is based in San Antonio, Texas, United States.
- Who is the new Chief Financial Officer at bioAffinity Technologies?
- bioAffinity Technologies named J. Michael Edwards Chief Financial Officer, announced October 10, 2024.
- What did bioAffinity Technologies announce on October 10, 2024?
- bioAffinity Technologies, Inc. announced the appointment of J. Michael Edwards as Chief Financial Officer (CFO), who will report directly to President and CEO Maria Zannes
- What does bioAffinity Technologies do?
- bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment.
- Where is bioAffinity Technologies based?
- bioAffinity Technologies is based in San Antonio, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Anavo Therapeutics (October 9, 2024), Immunome Inc. (October 8, 2024), Nuvation Bio (October 7, 2024) and Anixa Biosciences (October 7, 2024) also announced leadership changes within 45 days of bioAffinity Technologies.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Health Diagnostics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Anavo Therapeutics Appoints Edward Holson as Chief Scientific Officer and President of Anavo US (October 9, 2024)
- Immunome Appoints Roee Shahar as Executive Vice President, Commercial (October 8, 2024)
- Nuvation Bio Appoints Philippe Sauvage as Chief Financial Officer (October 7, 2024)
- Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development (October 7, 2024)
- Oak Hill Bio Promotes Josh Distler to Chief Executive Officer and Appoints Sharon Morriss as Chief Operating Officer (October 7, 2024)
- Orasis Pharmaceuticals Appoints Jeff Francis as Vice President of Sales and Sam Fakhoury as Vice President of Quality and Operations (October 14, 2024)
Who to call at bioAffinity Technologies, and when
A new leader at bioAffinity Technologies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day bioAffinity Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at bioAffinity Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at bioAffinity Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment bioAffinity Technologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
bioAffinity Technologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.